Detalhe da pesquisa
1.
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients.
Br J Haematol
; 193(2): 290-298, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33620106